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Induced pluripotent stem cells (iPSCs) undergo
extensive nuclear reprogramming and are generally
indistinguishable from embryonic stem cells (ESCs)
in their functional capacity and transcriptome and
DNA methylation profiles. However, direct conver-
sion of cells from one lineage to another often yields
incompletely reprogrammed, functionally compro-
mised cells, raising the question of whether pluripo-
tency is required to achieve a high degree of nuclear
reprogramming. Here, we show that transient ex-
pression of Gata3, Eomes, and Tfap2c in mouse fi-
broblasts induces stable, transgene-independent
trophoblast stem-like cells (iTSCs). iTSCs possess
transcriptional profiles highly similar to blastocyst-
derived TSCs, with comparable methylation and
H3K27ac patterns and genome-wide H2A.X deposi-
tion. iTSCs generate trophoectodermal lineages
upon differentiation, form hemorrhagic lesions, and
contribute to developing placentas in chimera
assays, indicating a high degree of nuclear reprog-
ramming, with no evidence of passage through a
transient pluripotent state. Together, these data
demonstrate that extensive nuclear reprogramming
can be achieved independently of pluripotency.
INTRODUCTION
The introduction of four transcription factors, Oct4, Sox2, Klf4,
and Myc (OSKM) into somatic cells can initiate a reprogramming
process that eventually yields stable and fully functional embry-
onic stem-like cells (also termed induced pluripotent stem cells
[iPSCs]) (Takahashi and Yamanaka, 2006). The notion that as
little as four factors are sufficient to reset the epigenome of a
cell opened a new avenue where scientists have attempted to
convert different adult cells into other somatic cell types byCellavoiding the pluripotent state using specific key master regula-
tors. Cell types such as hematopoietic cells, different neuronal
cells, cardiomyocytes, hepatocytes, embryonic Sertoli cells,
endothelial cells, b cells, and pigment cells were converted
from different somatic cells by employing the direct conversion
approach (Lee and Young, 2013; Xu et al., 2015).
However, in contrast to iPSCs that are stable and closely
resemble embryonic stem cells (ESCs) in their methylome, tran-
scriptome, and function (Buganim et al., 2014), many of the
directly converted cells are unstable (i.e., the cells are dependent
either fully or partially on their exogenous factors) and represent
only a partially reprogrammed state as estimated by their tran-
scriptional profile and function (Cahan et al., 2014; Morris
et al., 2014; Xu et al., 2015). This raises the question of whether
a high degree of nuclear reprogramming is a unique property of
cells undergoing reprogramming to pluripotency.
Trophoblast Stem Cells
In mammals, specialized cell types of the placenta mediate the
physiological exchange between the fetus and mother during
pregnancy. The precursors of these differentiated cells are
trophoblast stem cells (TSCs). In the pre-implantation embryo,
trophoblast cells are the first differentiated cells that can be
distinguished from the pluripotent inner cell mass and form the
outermost layer of the blastocyst (Cockburn and Rossant,
2010). In themouse, TSCs can be isolated and cultured from out-
growths of either the blastocyst polar trophectoderm (TE) or
extraembryonic ectoderm (ExE), which originates from the polar
TE after implantation (Tanaka et al., 1998). The trophoblast cell
lineage is the source for the most essential cell types of the
placenta. Therefore, TSCs have tremendous biomedical rele-
vance, as one-third of all human pregnancies are affected by
placental-related disorders (James et al., 2014).
Here, we demonstrate that transient ectopic expression of
three TSC key master regulators, Gata3, Eomes, and Tfap2c
together with Myc in fibroblasts, initiates a mesenchymal-to-
epithelial transition process that leads to the formation of a small
number of stable and transgene-independent-induced TSCs
(iTSCs) that resemble blastocyst-derived TSCs (bdTSCs) in their
transcriptome, epigenome, and function. iTSCs differentiatedStem Cell 17, 543–556, November 5, 2015 ª2015 Elsevier Inc. 543
Figure 1. Gata3, Eomes, and Tfap2C Are Sufficient to Induce Reprogramming of MEFs into TSC-like Colonies
(A) Schematic representation of the strategy to reprogram MEFs into iTSCs. MEFs were infected with the depicted dox-inducible lenti-viral vectors. Infected
MEFs were cultured in TSC reprogramming medium, containing dox for 20 days. Following 20 days of reprogramming, medium was replaced to TSC culturing
medium. Ten days after, epithelial colonies with TSC-like morphology were isolated and cultured on feeder cells.
(legend continued on next page)
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into all derivatives of the trophectoderm lineage in vitro, gave
rise to hemorrhagic lesions in nude mice, and chimerized the
placenta of the developing embryo, suggesting that iTSCs
acquired all hallmarks of native TSCs.
RESULTS
Ectopic Expression of Gata3, Eomes, and Tfap2c
Generates Stable Colonies that Are Similar in
Their Morphology and Gene Expression to
Trophoblast Stem Cells
We hypothesized that key master regulators that control early
embryonic development should possess nuclear reprogram-
ming capability, similarly to those expressed in pluripotent cells.
To test this hypothesis, we decided to convert fibroblasts into
trophoblast stem-like cells, which are the embryonic precursors
of the placenta and thus are restricted only to one layer.
To generate induced trophoblast stem cells (iTSCs), we
screened for transcription factors with a known role in tropho-
blast development and in reprogramming at large (Latos and
Hemberger, 2014; Niwa et al., 2005; Ralston et al., 2010; Russ
et al., 2000). Twelve transcription factors (12F): Tfap2c, Tead4,
Hand1, Dppa1, Gata3, Ets2, Elf5, Cdx2, Eomes, Myc, Utf1,
and Esrrb were cloned into doxycycline (dox)-inducible lentiviral
vectors and then used to infect mouse embryonic fibroblasts
(MEFs). To initiate the conversion process and select for stable
clones (i.e., colonies that can grow and maintain their character-
istics for prolonged culture time without exogenous factors),
we exposed the cells to dox for 20 days and then removed
dox for another 10 days (Figure 1A; for details see the Experi-
mental Procedures). Ten days post dox withdrawal, epithelial
colonies with TSC-like morphology developed in the dish (Fig-
ure 1A). We isolated five 12F-iTSC clones for further character-
ization. All isolated clones grew on mitomycin-c-treated
MEFs, and similarly to freshly isolated blastocyst-derived TSCs
(bdTSCs), could be weaned from feeder cells after five to ten
passages. To examine whether the cells activated their endoge-
nous TSC circuitry, wemeasured themRNA and protein levels of
several well-known TSC markers. As can be seen in Figure S1A,
all clones expressed high endogenous mRNA levels of the TSC
markers: Elf5, Cdx2, Esrrb, Utf1, Tead4, and Hand1 (Figure S1A)
and a high protein level of Esrrb, Utf1, Cdx2, and Elf5 (Figure 1B,
representative clone is presented). To identify the minimum
number of transcription factors that are required for generating
iTSCs, we analyzed the five 12F-iTSC clones for their transgene
integrations by qPCR. Surprisingly, although Cdx2 has been
shown to be essential for determining TSC fate by counteracting(B) Bright field images and immunostaining against Esrrb, Utf1, Elf5, and Cdx2 in
(C) Bright field images of stable iTSC clones generated by three factors (3F, GE
with mixed C57BL/6 3 129 background. Top: shows clones that grew under stan
TSCmedium +FGF4 (25 ng/ml), and heparin (1 mg/ml). Bottom: shows colonies th
(1 mg/ml), and Tgfb1 (2 ng/ml) on Matrigel.
(D) Bright field images of a stable iTSC colony generated by 3F from MEFs isola
(E) A stable iTSC colony expressing endogenous Sox2-GFP, generated by 4F fro
and GFP channel.
(F) Left: a stable iTSC colony generated by 4F from Sox2-GFP MEFs expressing e
MEFs shows lack of Oct4-GFP expression. Cells were imaged using the bright fi
(G) qPCR of the indicated genes normalized to Gapdh in MEFs, 3 and 4 factors
See also Figure S1.
Cellpluripotency via the repression of Oct4 (Niwa et al., 2005;
Strumpf et al., 2005), the only factors that were present in all
five clones were Gata3, Eomes, and Tfap2c (Figure S1B). In
accordance with that, expression of Gata3, Eomes, and Tfap2c
(GET or 3F) was sufficient to generate iTSC clones (Figure 1C,
two isolated stable clones are presented, upper panel). It is
important to note that two of the 12 factors, Ets2 and Tead4,
were present in four out of the five examined clones (Figure S1B),
suggesting these factors have a positive effect on the reprog-
ramming process. Since Myc was shown to be a global gene
amplifier (Lin et al., 2012; Nie et al., 2012; Soufi et al., 2012),
we tested whether ectopic expression of Gata3, Eomes, Tfap2c,
and Myc (GETM or 4F) enables the formation of iTSCs (Figures
1C, two isolated stable clones are presented, upper panel, and
S1C). To measure reprogramming efficiency, MEFs harboring a
GFP reporter in the endogenous locus of the TSC/ESC marker
Sox2 (Adachi et al., 2013), were infected with either GET or
GETM. While GET produced an average of 112 Sox2-GFP-pos-
itive colonies per 33 105 seeded cells, GETM produced2-fold
more Sox2-GFP-positive colonies (an average of 196 colonies,
Figures S1D). Since more cells could initiate proliferation
following Myc addition (Figure S1E), we believe that one of its
main effects in boosting the reprogramming to iTSCs is by over-
coming contact inhibition and senescence.
All isolated clones from GET (3F) and GETM (4F) grew for
several passages under standard TSC culture conditions and
could be weaned from feeder cells after five to ten passages.
In addition, the clones could also be maintained under recently
published defined medium and culture conditions (Kubaczka
et al., 2014) (Figure 1C, lower panel) and exhibited a correct
composition of transgenes in their genome (Figure S1F) with
non-leaky or minor leaky expression of the transgenes (Fig-
ure S1G). iTSC clones were also generated from inbred strains
such as C57BL/6 (Figure 1D) and adult tail-tip fibroblasts
(TTFs) expressing Sox2-GFP, but with reduced efficiency (Fig-
ures 1E and S1D). Importantly, while the Sox2-GFP reporter
was highly activated in iTSCs, the pluripotent reporter Oct4-
GFP remained silent (Figures 1E and 1F). Fluorescence-
activated cell sorting (FACS) analysis of Sox2-GFP-positive cells
on one representative Sox2-GFP 4F-iTSC clone that grew either
on feeder under standard TSC culture conditions or on Matrigel
under defined culture conditions revealed a highly homogenous
expression of Sox2 (83.4% and 98.9%, respectively, Fig-
ure S1H). Expression of the TSC-specific genes, Cdx2, Elf5,
Tfap2c, Ets2, Tead4, and Eomes was comparable between
various iTSC clones and two bdTSC lines, TSCblast#1 and
TSCblast-B6#1, (Figures 1G and S1I). Moreover, the expressionstable iTSC clone generated by 12 factors (12F). Scale bar, 100 mM.
T) and four factors (4F, GETM) and of bdTSC clone, TSCblast#1, all from mice
dard TSC culture conditions: 70% MEF conditioned medium (MEF-CM), 30%
at grew under defined culture condition: TX medium +FGF4 (25 ng/ml), heparin
ted from C57BL/6 mice.
m Sox2-GFP tail-tip fibroblasts (TTFs). Cells were imaged using the bright field
ndogenous Sox2-GFP. Right: a stable iTSC colony generated from Oct4-GFP
eld and GFP channel.
representative iTSC clones, bdTSC clones, and ESCs.
Stem Cell 17, 543–556, November 5, 2015 ª2015 Elsevier Inc. 545
of the pluripotent-specific genes, Nanog, Oct4, and Dppa3, and
the expression of the fibroblast-specific genes, Thy1, Col5a2,
and Postn was absent in all examined iTSC clones and bdTSCs
(Figure 1G). In total, we isolated and cultured 18 3F-iTSC clones
and 24 4F-iTSC cloneswith isolation efficiency of50%of Sox2-
GFP-positive colonies becoming stable iTSC clones. The results
so far suggest that the introduction of Gata3, Eomes, and Tfap2c
into somatic cells generates stable colonies that can be main-
tained in culture independently of their exogenous factors and
are similar in their morphology and TSC-specific marker expres-
sion to bdTSCs.
Introduction of Gata3, Eomes, Tfap2c, and Myc into
Fibroblasts Induces Rapid Mesenchymal-to-Epithelial
Transition
Mesenchymal-to-epithelial transition (MET) is an essential pro-
cess for proper embryonic development and is initiated early
on during the conversion of fibroblasts into epithelial cells such
as iPSCs and Sertoli cells (Buganim et al., 2012a, 2012b). Since
TSCs are epithelial cells, we sought to examine at what time
point during the conversion the induced fibroblasts undergo
MET. First, we monitored the morphology of the induced cells
for 8 days following GET expression alone or in combination
withMyc. To clearly observe themorphology of the induced cells
overtime, we plated the cells at low density. As can be seen in
Figure 2A, a morphological change can already be observed
after 2 days of GETM expression. On day 8, a large number of
epithelial colonies developed in the plate due to increased prolif-
eration, suggesting that MET is an early event in the reprogram-
ming process to iTSCs with GETM. In contrast, when fibroblasts
were infected with GET alone, fewer colonies developed in the
plate, and clear epithelial colonies could be seen only on day
12 of dox exposure, suggesting a less prominent MET process
(Figure 2B). To investigate how GETM initiate MET, we moni-
tored the mRNA levels of several key genes that were shown
to play amajor role in the opposite process, epithelial-to-mesen-
chymal transition ((EMT) (Figure 2C). A substantial downregula-
tion of key EMT genes such as Twist1, Zeb2, Snai2, Foxc2,
Gsc,Mmp3, and Snai1was noted after 2 days of factor induction
and remained low for the first 8 days (Figures 2D and S2A).
Consequently, a sharp decrease was observed in mesenchymal
markers such asCdh2,Des, Fn1, andCldn1 and a gradual eleva-
tion in epithelial markers such as Cdh1, Krt18, Dsp, and Ocln
(Figures 2E, 2F, S2B, and S2C). The same trend was observed
with GET but to a much lesser extent (Figure S2D), suggesting
that Myc contributes to the induction of the MET process. This
is in agreement with a previous study demonstrating that Myc
alone is sufficient to downregulate mesenchymal markers
(Sridharan et al., 2009). Upregulation of the epithelial markers
Krt18 and Cdh1, and downregulation of the mesenchymal
marker Acta2, were also observed at the protein level (Figure 2G).
Interestingly, the expression levels of the epithelial markersKrt18
and Ocln, and the mesenchymal markers Twist1, Zeb2, Cdh2,
and Snai1, were similar between TSCs and induced cells and
different from ESCs. These results suggest that MET is an early
and robust phenomenon occurring during the conversion to
iTSCs and that expression of GET or GETM in mesenchymal
cells induces epithelial morphology with characteristics resem-
bling those of bdTSCs.546 Cell Stem Cell 17, 543–556, November 5, 2015 ª2015 Elsevier IniTSCs Exhibit Similar Transcriptome and Karyotype to
Those of bdTSCs
One indication for a stable conversion and a high degree of nu-
clear reprogramming state is the capability of the induced cells
to activate their endogenous circuitry (Buganim et al., 2013).
Incomplete activation of the endogenous circuitry will lead to a
partially similar transcriptional profile, as can be seen in many
direct conversion models (Cahan et al., 2014; Morris et al.,
2014). To assess whether isolated iTSCs activate their endoge-
nous circuitry, we subjected two 12F-iTSC clones, two 4F-
iTSC clones, and two 3F-iTSC clones for RNA-sequencing
(RNA-seq) analysis. Two bdTSC clones and parental MEFs and
ESCs were used as positive and negative controls, respectively.
Notably, the various iTSC clones clustered together with bdTSC
clones and far away from the MEF and ESC controls, as indi-
cated by hierarchical clustering analysis (Figure 3A). Importantly,
one of the bdTSC lines, TSCblast#1, clustered closer to the three
induced TSC clones, 4F-iTSC#1, 3F-iTSC#3, and 3F-iTSC#4,
than to the other bdTSC line, TSCblast-B6#1 (Figure 3A). Principle
component analysis (PCA) (Figure 3B), scatter plots (Figure 3C),
and an unbiased clustering heatmap of the top 10,000 ex-
pressed genes (Figure S3A) confirmed the results obtained by
hierarchical clustering and demonstrated a highly similar tran-
scriptome between bdTSCs and iTSCs.
Stress induced by oncogenes such asMyc leads to DNA dam-
age that promotes genomic instability and tumor progression.
Thus, we asked whether iTSCs acquire genomic aberrations in
the course of the reprogramming process. To this end, we exam-
ined the chromosomal content of iTSC clones by whole genome
single-cell sequencing and compared it to bdTSCs, MEF, and
ESC controls. Single-cell sequencing libraries were made from
nine cell lines (ESCs, parental MEFs, three 3F-iTSC, two 4F-
iTSC, and two bdTSC clones) that were cultured for at least
20 passages. Notably, although a larger number of chromosomal
aberrations was noticed in all TSC lines compared to ESC and
MEF controls, the iTSC clones exhibited a comparable extent
of abnormal chromosomal content to the two bdTSC lines, sug-
gesting that the reprogramming process per se, did not lead
to an increased number of genomic aberrations (Figure S3B).
We also mapped sister chromatid exchanges (SCEs), a sensitive
indicator of genomic stress, in seven lines using Strand-seq
(Falconer et al., 2012). Analysis of average SCE rates in all lines
showed no significant differences between any of the cell types
(Figure S3C, representative library is present in Figure S3D). The
results so far suggest that iTSCs resemble bdTSCs in their
transcriptome and genomic stability.
iTSCs Exhibit Comparable Methylation and Epigenome
Patterns and H2A.X Deposition to bdTSCs
A high level of nuclear resetting refers to the remodeling of a new
epigenome that is similar to the corresponding cell type. To test
whether iTSCs acquired epigenetic marks that are specific
to TSCs, we measured the DNA methylation status of one
TSC-specific locus (i.e., a locus that is hypomethylated in
TSCs but hypermethylated in MEFs and ESCs), the Elf5 pro-
moter, and one ESC-specific locus, the Nanog promoter, in
two iTSC clones, two bdTSC clones, and the parental MEFs
and ESCs by bisulfite conversion and sequencing. As can be
seen in Figure 4A, while the Elf5 promoter exhibited robustc.
Figure 2. Reprogramming to iTSCs Begins with the Initiation of a Mesenchymal-to-Epithelial Transition
(A and B) Representative bright field images showing the formation of epithelial foci within the indicated days of iTSC reprogramming with GETM (A) or GET (B).
(C) Schematic representation of the mesenchymal-to-epithelial transition (MET) process and key factors that block it (modified from Buganim et al., 2012b).
(D–F) qPCR of the indicated genes, normalized to Gapdh in MEFs, MEFs on dox for the indicated amount of days, bdTSCs, and ESCs.
(G) Representative immunostaining images depicting the protein levels of the epithelial markers Krt18 and Cdh1 and the mesenchymal marker Acta2 in cells
ectopically expressing GETM for 12 days. Lower panel: immunostaining images depicting the protein levels of Cdh1 in bdTSCs and in the 4F-iTSC#1 clone.
See also Figure S2.
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Figure 3. Unbiased Comparative Transcrip-
tome Analyses Clusters iTSCs with bdTSCs
and Far from ESCs or MEFs
(A) Hierarchical clustering of global gene expres-
sion profiles for two RNA-seq technical replicates
for the indicated iTSC, bdTSC, ESC, and MEF
lines. Replicate pairs were assigned a shared
numerical value.
(B) Principle component analysis for genes from
(A). PC1, 27%; PC2, 19%. Each of the iTSC,
bdTSC, ESC, and MEF lines is marked by a spe-
cific color. The group names correspond to the
names in (A).
(C)Scatterplots for the indicatedcomparisons.Blue
line shows the linear representation of the data,
black line shows the y = x line. Red dots show the
position of the indicated genes. All examined TSC
and iTSC clones grew under defined TX medium.
See also Figure S3 and Table S1.hypomethylation in all examined iTSC and bdTSC clones, it re-
mained hypermethylated in ESC and MEF controls (Figure 4A).
In contrast, the Nanog promoter was hypomethylated only in
the ESC control sample.
Several loci have been suggested to act as gatekeepers in the
transdifferentiation of mouse ESCs to TSC-like cells upon
manipulation of lineage-determining transcription factors such
as Cdx2 and Oct4 (Cambuli et al., 2014). These regions exhibited
a higher methylation status and lower gene expression in all
transdifferentiation models as compared to bdTSCs. Thus, we
examined the expression level of these gatekeeper genes in
various iTSC clones. As can be seen in Figure 4C, although
some variation in gene expression was noticed in a number of
genes, the overall gene expression was comparable between
iTSC clones and the two bdTSCs (Figure 4C). Methylation anal-
ysis of one representative locus, theHand1 promoter, revealed a
robust hypomethylation in bdTSC and iTSC lines compared to
MEF control (Figure S4A). Interestingly, hypomethylation was
also observed in ESC, suggesting that the Hand1 promoter re-
gion (110 to +40) is not ideal for discriminating between the
methylation status of ESC and TSCs.
The histone mark H3K27ac identifies accessible chromatin
throughout the genome and can separate active from poised
enhancers (Creyghton et al., 2010). Thus, we tested whether
TSC-specific regions are more enriched with H3K27ac in
bdTSCs and iTSCs than in MEF and ESC controls. In agreement
with their capability to express the Cdx2 and Hand1 genes, to
repress the fibroblast Thy1 and Postn genes, and to retain low
levels of the ESC genes Nanog and Oct4, bdTSCs and iTSCs
showed high H3K27ac levels only for the Cdx2 and Hand1 loci
while retaining low H3K27ac levels for Nanog, Oct4, Thy1, and
Postn following chromatin immunoprecipitation (ChIP)-qPCR
analysis (Figure S4B). The results so far indicate that the epige-
nome of iTSCs was rewired to be equivalent to that of bdTSCs,
as assessed bymethylation and H3K27ac enrichment of specific548 Cell Stem Cell 17, 543–556, November 5, 2015 ª2015 Elsevier Inc.loci, and suggests an explanation for the
low expression of the Hand1 gene in
ESCs, although hypomethylated in its
promoter region (Figure S3A).Genome-wide organization of histone variant H2A.X is cell
type dependent. Abnormal H2A.X deposition is frequently
observed in iPSC clones generated by OSKM factors that failed
to support ‘‘all-iPSC’’ mice development (Wu et al., 2014). In
contrast, iPSCs that are generated with other reprogramming
factors, such as, Sall4, Nanog, Esrrb, and Lin28 (SNEL), mostly
support the development of ‘‘all-iPSC’’ mice and show normal
H2A.X deposition (Buganim et al., 2014). We thus examined
the genome-wide H2A.X deposition patterns of two 3F-iTSC,
two 4F-iTSC, and two bdTSC clones and compared them to
ESC and MEF controls, using chromatin immunoprecipitation
sequencing (ChIP-seq). H2A.X deposition patterns in all exam-
ined iTSC clones closely resembled bdTSC clones and were
significantly different (p < 1.0E-100) from MEF and ESC controls
(Figure 4D, the deposition patterns of H2A.X in four different
chromosomes are presented in Figures 4E and S4C). These
data suggest that iTSCs have acquired key epigenetic land-
scape signatures of TSCs during the conversion process.
iTSCs Function Similarly to bdTSCs
Cells acquiring a high degree of reprogramming state should
exhibit all the functions of their corresponding cells, as can be
seen in the case of high quality iPSCs and ESCs. To test whether
iTSCs are capable of executing the functions exerted by
bdTSCs, we subjected them to three gold-standard tests. First,
we examined whether iTSCs are multipotent and capable
of differentiating into trophoblast lineages represented in the
placenta. iTSCs were cultured on gelatin without Fgf4 and
heparin for 10 days and, after 2 days, differentiated giant
multinucleated cells, associated with primary trophoblast cells,
were noted in the plate (Figure 5A, second image from the left).
The presence of multinucleated cells and their growing number
over the differentiation period was evident also by flow cytome-
try analysis with propidium iodide (PI) (Figure 5B). Accordingly,
we observed a gradual elevation in gene expression of the
Figure 4. Promoter Methylation Analysis of Elf5 and Nanog and H2A.X Deposition Demonstrate High Similarity between iTSCs and bdTSCs
(A and B) Bisulfite analysis of the promoter regions of Elf5 (652 to 263) and Nanog (399 to +49) in bdTSCs, iTSCs, ESCs, and MEFs. Each circle (empty-
hypomethylated and full hypermethylated) represents one CG sequence in the depicted locus and each row represents one PCR product that was cloned into TA
cloning vector and sequenced.
(C) A graph summarizing the expression levels of the indicated gatekeeper genes in the indicated samples as measured by RNA-sequencing.
(D) A bar chart summarizing the number of differential H2A.X deposition domains (compared to TSCblast#1 control line) in the indicated iTSC and bdTSC lines,
MEFs and ESCs (p value < 1.0E-100, chi-square test).
(E) Comparative H2A.X depositions in the indicated iTSC clones, bdTSCs, ESCs, and MEFs at chromosome 15 (Chr15). y axis: relative H2A.X deposition level
(RSEG enrichment score, compared to bdTSC control line, see Supplemental Experimental Procedures). Positive value: regions enriched for H2A.X deposition
over control; negative values: regions devoid of H2A.X deposition over control.
See also Figure S4 and Table S1.
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Figure 5. iTSCs Are Fully Functional
(A) Bright field images of iTSCs grown in differen-
tiation medium (10% FBS DMEM medium without
Fgf4 and heparin) for the indicated days.
(B) Flow cytometry analysis of iTSCs grown in dif-
ferentiationmedium for the indicateddays following
propidium iodide (PI) staining. Gates show PI
staining intensities, indicating DNA copy number.
The percentage of cells from each sample in every
phase is indicated. PI was measured with filter Fl3.
(C) A representative hemorrhagic lesion, 7 days
after subcutaneous injection of iTSCs (53 106) into
a nude mouse.
(D) H&E staining of paraffin sections of hemor-
rhagic lesions. Left: low power image. Right: higher
power image showing necrotic tissue with blood
and scattered giant cells (arrow).
(E) Left: a stable iTSC colony, 3F-
iTSCB6/R26-tdTomato#4, with constitutive tdTomato
expression from the Rosa26 locus. Cells were
imagedusing thebright fieldand redchannel. Right:
3F-iTSCB6/R26-tdTomato#4 cells were injected into 8-
cell stage embryos and analyzed at the hatched
blastocyst stage using fluorescent microscopy.
(F) 4F-iTSCH2b-GFP#1 cells were injected into 8-cell
stage embryos and analyzed at the hatched blas-
tocyst stage using confocal fluorescent micro-
scopy. Blastocysts were stained for Cdx2 (red) to
detect trophectoderm cells, and for Nanog (white)
to detect cells from the inner cell mass. Co-local-
ization of H2b-GFP nuclei and Cdx2 nuclei is
depicted by white arrows (yellow staining).
(G) Contribution of H2b-GFP iTSCs, 3F-
iTSCH2b-GFP#1, to the developing 13.5 dpc
placenta. A clear H2b-GFP signal was detected in
several patches within the placenta (white squares)
and was completely absent in the embryo. Pla-
centas were imaged using green and red channels
to detect autofluorescence. A magnification of one
region is illustrated by dashed lines. White oval
shows autofluorescent structure.
(H) Immunostaining of GFP in placental tissue
isolated from E13.5 fetus following blastocyst in-
jection of 4F-iTSCH2b-GFP#5 cells shows nuclear
GFP staining.
(I) Immunostaining of GFP and Tfap2c in placental
tissue isolated from E13.5 fetus following blasto-
cyst injection of 3F-iTSCH2b-GFP#1 cells shows
double positive yellow cells (white arrows).
See also Figure S5 and Table S1.specific trophoblast giant cell markers Ctsq, Prl3b1, Prl3d1, and
Prl2c2 (Simmons et al., 2007) in two iTSC clones and one bdTSC
clone following differentiation (Figure S5A). Other trophoblast-
lineage markers such as Tpbpa (specific for spongiotrophoblast
cells) (Simmons and Cross, 2005) and Cga (specific for syncytio-
trophoblast cells) (Anson-Cartwright et al., 2000) were elevated
as well, and undifferentiated TSC markers such as Cdx2 and
Eomes (Ng et al., 2008) were downregulated during differentia-
tion (Figure S5A).
The formation of a transient hemorrhagic lesion under the skin
of a nude mouse by transplanted bdTSCs recapitulates the
invading properties of the trophoblast giant cells during implan-
tation (Kibschull et al., 2004). Similar to bdTSCs, when injected
subcutaneously into nude mice, iTSCs formed lesions that550 Cell Stem Cell 17, 543–556, November 5, 2015 ª2015 Elsevier Inreached their maximum size 5–8 days following injection and
thereafter began to resorb (Figure 5C). Some of the lesions
were excised and analyzed by H&E staining, revealing a typical
structure of trophoblastic hemorrhagic lesion with big blood-
filled lacunas and differentiated trophoblastic giant cells (Fig-
ure 5D). Next, we tested whether iTSCs can function properly
in their native environment. First, we injected tdTomato-iTSCs
into 8-cell stage embryos and followed the localization of the in-
jected cells at the blastocyst stage. Notably, the vast majority of
the cells migrated toward the outer layer of the blastocysts in
accordance with their role as extraembryonic cells (Figure 5E).
To accurately localize the cells inside the blastocyst we infected
iTSCswith H2b-GFP lentiviral vector to better visualize the nuclei
of the cells (Figure S5B). H2b-GFP marked iTSCs were injectedc.
into eight-cell-stage embryos that were cultured until the blasto-
cyst stage. The blastocysts were then fixed and stained for Cdx2
and Nanog and analyzed by confocal fluorescent microscopy.
As can be seen in Figure 5F, the injected H2b-GFP iTSCs were
negative for Nanog, positive for Cdx2, and localized to the extra-
embryonic region similarly to bdTSCs (Figures 5F and S5C, left
panel). Importantly, many of the injected H2b-GFP-positive
bdTSCs or iTSCs lose the expression of Cdx2 during blastocyst
maturation (Figure S5C, right panel), proposing an explanation
for the low contribution efficiency of bdTSCs to developing
placenta seen following blastocyst injection (Cambuli et al.,
2014). Moreover, this observation suggests an active mecha-
nism inside the blastocyst to shot off any cell that is wrongly
localized in the blastocyst.
It has been shown that bdTSCs can contribute to the formation
of the placenta when injected into blastocysts (Niwa et al., 2005;
Tanaka et al., 1998). Thus, we asked whether iTSCs could
chimerize the developing placenta as well. Examination of
13.5 days post-coitum (dpc) placentas by fluorescent micro-
scope revealed many structures with high autofluorescence
activity both in the green and red channels. We therefor used
again H2b-GFP iTSCs, as nuclear GFP signal is unique and
can be easily distinguished from other structures of the placenta.
Marked clones were injected into blastocysts that were then
transferred into pseudopregnant females. On 13.5 dpc, pla-
centas and embryos were isolated and analyzed. A clear H2b-
GFP signal was detected in some placentas (an average of 2
out of 15 examined placentas) in several patches and was
completely absent from all embryos (representative patches of
nuclear-GFP cells are depicted in Figures 5G, 5H, S5D, and
S5E). To examinewhether the cells differentiated into the tropho-
blast lineage, we stained the placenta with Tfap2c antibody. As
can be seen in Figure 5I, double-positive cells for H2b-GFP
(green) and Tfap2c (red) were detected in 13.5 dpc placentas
(Figure 5I). Importantly, a comparable contribution was seen
following the injection of a bdTSC line, TSCblast-H2b-GFP#1 (data
not shown). These data suggest that iTSCs are fully functional
cells with the capability to recapitulate the tasks exerted by
bdTSCs.
The Conversion of Fibroblasts into iTSCs Does Not
Occur via a Defined Pluripotent State
Since ESCs and TSCs share the expression of several key genes
(e.g., Sox2, Sall4, Utf1, Esrrb) (Figures 1B, S1A, and S6A), and
because Gata3 was shown to induce pluripotency in other com-
binations of factors (Montserrat et al., 2013; Shu et al., 2013), we
examined whether the conversion to iTSCs goes through a
defined pluripotent stage. First, we tried to obtain iTSCs by
ectopic expression of OSKM in cells that grew under culture con-
ditions of TSCs. As a control, we cultured the cells also under
ESC culture conditions. MEFs that harbor the Nanog-GFP or
Oct4-GFP reporters were used becauseNanog andOct4 are ex-
pressed solely and specifically in pluripotent cells (Figure 1G).
Transduced MEFs were exposed to dox for 13 days, after which
it was removed for 6 days. As can be seen in Figure 6A, we
observed only differentiated cells (right panel) or stable iPSCs
(left panel) that were also positive for the Nanog-GFP or Oct4-
GFP reporters in the dish of both culture conditions (Figure 6A).
The number of GFP-positive cells was drastically lower whenCellTSC culture conditions were used, suggesting that reprogram-
ming with TSC culture conditions is suboptimal for acquiring a
stable pluripotent state (Figure 6A) and that the acquisition of a
pluripotent state is not beneficial for the formation of iTSCs.
Next, we tried to obtain iPSCs by using the TSC reprogramming
factors, GETM. The cells were cultured either under standard
ESC culture conditions (serum and LIF), or under optimal mouse
ESC culture conditions (LIF and 2i, GSK3b and Mek 1/2 inhibi-
tors) to facilitate pluripotency. We were unable to attain stable
iPSCs in all examined conditions, even when the cells were
exposed to dox for a longer period of time (data not shown).
We next asked whether Nanog or Oct4 are activated during
the reprogramming process to iTSCs. The presence of Nanog-
GFP- or Oct4-GFP-positive cells during the reprogramming pro-
cess might suggest that these cells acquire a short and transient
pluripotent state. To this end, we repeated the above experi-
ments, but this timewe analyzed the reprogrammable cells every
3 days by flow cytometry. Figure S6B shows that, in general,
GFP-positive cells were undetectable during the 12 days of the
reprogramming process. In some rare cases, we did observe a
very small number of GFP-positive cells, but since multiple
attempts to culture these cells (following sorting), either under
TSC or ESC culture conditions, never gave rise to any growing
cells, we believe this observation was either due to a high auto-
fluorescent activity of dead cells in the green channel or as a
results of an aberrant activation of the Nanog or Oct4 locus (Fig-
ure S6B). Supporting this is the observation that even an early
and robust marker for pluripotency such as Fbxo15was not acti-
vated following GETM induction (Figure S6C). In addition, iTSC
colonies could be obtainedwhen JAK inhibitor (JAKi), that blocks
Stat3 phosphorylation, was added to the reprogramming me-
dium (Figure S6D), and even when we looped out Oct4 from
the starting MEFs (i.e., Sox2-GFP MEFs harboring Oct4 lox/lox
homozygous alleles) (Kehler et al., 2004) using a lentiviral vector
encoding for Cre (Figure 6C). To rule out the possibility that
GETM induces a hyperdynamic chromatin state (Buganim
et al., 2013) or transient pluripotency phase (Bar-Nur et al.,
2015) similarly to OSKM, we repeated the protocol by Efe et al.
(2011) for inducing cardiomyocytes from fibroblasts. Notably,
while we obtained a large number of cardiomyocyte colonies
when we used OSKM as reprogramming factors, we never
detected cardiomyocyte colonies while employing the GETM
reprogramming factors, even when the reprogramming factors
were expressed for a longer period of time (Figures 6D and
6E). The OSKM-derived cardiomyocyte colonies were positive
for the cardiomyocyte marker Tnnt2 and approximately half of
them were beating (Figures 6E, 6F, and S6E; Movies S1 and
S2). These results suggest that the GETM reprogramming factor
combination is specific for the trophectoderm lineage and that
iTSC formation does not go through a defined pluripotency
phase.
DISCUSSION
To convert one cell type to another and to reach a high degree of
nuclear reprogramming state, the key master regulators of the
targeted cell type must first be identified and then ectopically
expressed. To complete the conversion process and to achieve
a stable and fully functional cells, the exogenous factors must beStem Cell 17, 543–556, November 5, 2015 ª2015 Elsevier Inc. 551
Figure 6. Reprogramming to iTSCs Occurs Directly via the Extraembryonic Lineage and Not via a Pluripotent State
(A and B) Bright field and green channel images and FACS analysis of iPSCs generated by OSKM expression in Nanog-GFP (A) or Oct4-GFP (B) MEFs grown in
ESC or in TSC medium. Note that in the left panels a stable iPSC colony is presented and in the right panels differentiated cells under TSC culture conditions are
presented.
(C) Upper left: schematic representation of strategy for inducing iTSC or iPSC clones without Oct4 presence. Two days prior to day 0, Sox2-GFP; Oct4 lox/lox
MEFs (Kehler et al., 2004) were infected with dox-inducible GETM or with OSKM in combination with FUW-M2rtTA-2A-puro and FUW-Zeo-Cre or with FUW-Zeo-
TetO empty vector. Starting on day 0, MEFs underwent 20 days of dox treatment, followed by 10 days without dox. Puromycin and Zeocin were added during the
(legend continued on next page)
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downregulated, either by the cells (i.e., silencing) or by inducible
systems.
Following the discovery of iPSCs, many other cell-type-spe-
cific key master regulators have been suggested to convert
somatic cells by avoiding the pluripotent state. However, a
high nuclear reprogramming state was evident only in iPSCs.
This observation raised the hypothesis that complete nuclear
resetting is a unique property for cells undergoing reprogram-
ming to pluripotency. To test this hypothesis, we decided to
convert fibroblasts into trophoblast stem-like cells. We chose
TSCs because first, they are embryonic cells, and, in contrast
to iPSCs, are committed only to one lineage, the trophectoderm.
Second, key TSC master regulators such as Cdx2, Tead4,
Eomes, Tfap2c, and Elf5 oppose the pluripotent state by repres-
sing the core pluripotency circuitry, thus minimizing the possibil-
ity that the conversion to iTSC will go through a pluripotent state
(Adachi et al., 2013; Chen et al., 2010; Niwa et al., 2005). Third, to
date, all attempts to isolate and culture human TSCs in their
undifferentiated state were unsuccessful (Genbacev et al.,
2013). Identifying the combination of TSC key master regulators
that can activate the TSC core circuitry in the murine model
might aid in attaining the human undifferentiated state following
expression of their human orthologs, as was shown recently to
be the case for human naive-like ESCs by the transient ectopic
expression of NANOG and KLF2 (Takashima et al., 2014; Theu-
nissen et al., 2014). Fourth, recurrent miscarriage and fetal
growth restriction (FGR) are associated with placental dysfunc-
tion and contribute to handicaps and in severe cases, fetal
death. The generation of stable and fully functional human iTSCs
will aid in modeling these diseases and, in the future, might pro-
vide a platform for cellular transplantation of intact and healthy
iTSCs into undeveloped/damaged placenta (James et al., 2014).
It has been shown that ESCs can acquire trophoblast stem-
like characteristics upon manipulation of lineage-determining
transcription factors such as Cdx2, Elf5, Eomes, Tfap2c,
Gata3, Oct4, or following activation of the extracellular signal-
regulated kinase 1/2 (Erk1/2) pathway (Cambuli et al., 2014;
Kuckenberg et al., 2010; Lu et al., 2008; Ng et al., 2008; Nishioka
et al., 2009; Niwa et al., 2000, 2005; Ralston et al., 2010).
Although transdifferentiation into trophoblast stem-like cells
was initiated following these manipulations, lineage conversion
remained incomplete in all models as evidenced by the failure
to demethylate a small group of TSC genes such as Elf5,entire course of the experiment. Clones from all plates were picked on day 30 an
for the recognition of Cre activity on Oct4 loxP sites, as described previously (Ke
alleles and a 1,421 or 1,455 bp fragment fromWT or floxed alleles, respectively. N
the overall number of colonies was reduced compared to WT cells. The very
contained the Cre plasmid, escaped recombination and did not deleted Oct4 as
fragment from Oct4 WT alleles or a 532 bp fragment from Oct4 floxed alleles
representative images of iTSC (left) and iPSC (right) colonies, with or without Cre
(D) Direct reprogramming to cardiomyocytes. MEFs infected with dox-inducible
JAK inhibitor (JAKi) for 6 or 10 days, followed by 3 days of dox withdrawal. Cells
supplemented with BMP4 for 5 days, followed by 7 days of BMP4 withdrawal. B
while non-beating colonies generated by GETM are seen on the right.
(E) Graph summarizing the percentages of beating and non-beating colonies ou
10 days following dox induction.
(F) Left: bright field images and immunostaining against Tnnt2 in a beating colony
and immunostaining against Tnnt2 in cells infected with GETM, 10 days followin
See also Figure S6 and Movies S1 and S2.
CellTead4, and Ezr (Cambuli et al., 2014). Importantly, failure to de-
methylate this small group of loci was accompanied by reduced
levels of their corresponding genes. Forced expression of the
genes from these non-reprogrammed loci improved transdiffer-
entiation efficiency, but still failed to confer a stable TSC pheno-
type (Cambuli et al., 2014). These data suggest that the optimal
combination of factors that can completely activate the TSC core
circuitry has not been identified to date.
Here, we describe a method to generate stable and fully func-
tional TSC-like cells from murine fibroblasts by transient ectopic
expression of three TSC key master regulators, Gata3, Eomes,
and Tfap2c. Surprisingly, the two key TSC master regulators,
Cdx2 and Elf5, were dispensable for the reprogramming pro-
cess. The induced TSCs grew independently of the exogenous
factors for a large number of passages and resembled bdTSCs
in their morphology, transcriptome, methylation, and epigenetic
status (as evident from several specific loci), H2A.X organization,
and function (Table S1).
Whole transcriptome analyses demonstrated that the tran-
scriptome of iTSCs is highly similar to bdTSCs, as one of the
two bdTSC lines clustered closer to three iTSC clones than to
the second bdTSC line. One of the loci that was relatively hyper-
methylated in all transdifferentiation models described above is
the stringently regulated gatekeeper gene, Elf5. While 16% of
this locus was methylated in bdTSCs, in the Oct4-downregula-
tion transdifferentiation model and in the Cdx2 overexpression
model, it was 26.5% and 64%, respectively (Cambuli et al.,
2014). In the current study, measuring the methylation status of
the Elf5 promoter in two bdTSC lines (2% and 10%) and in two
iTSC clones (10% and 12%) revealed robust and comparable
hypomethylation. However, given the low efficiency of the re-
programming process, compared with the very high rate of
transcription factor induced conversion of ESCs to TSCs, it is
plausible to assume that there is a small population of cells pre-
sent within ESC-derived TSC-like populations that is equivalent
to bdTSCs. These data suggest that the conversion of fibroblasts
into iTSCs represents a very high degree of nuclear reprogram-
ming and refute the hypothesis that complete nuclear reprog-
ramming can be achieved only in cells undergoing conversion
to ESC-like cells. Similar to the initial studies in iPSCs, this
method of conversion still needs fine-tuning and optimization
such as identifying the ideal culture conditions and the best
stoichiometry of the reprogramming factors.d genomic DNA was purified. Upper right: semiquantitative PCR using primers
hler et al., 2004). Up: primer pair C, producing a 245 bp fragment from deleted
ote that we could isolate only iTSC colonies withOct4 deleted alleles, although
few stable iPSC clones that emerged from the reprogramming process that
indicated by a 1,455 PCR product. Bottom: primer pair A, producing a 498 bp
or no PCR product (white asterisk) from Oct4 deleted alleles. Lower panel:
expression.
OSKM or GETM factors were exposed to reprogramming media containing
were then differentiated to cardiomyocytes by a chemically defined medium
right field images of beating colonies generated by OSKM are seen on the left,
t of the total ‘‘n’’ number of colonies generated by OSKM or by GETM, 6 and
generated by OSKM, 10 days following dox induction. Right: bright field images
g dox induction.
Stem Cell 17, 543–556, November 5, 2015 ª2015 Elsevier Inc. 553
EXPERIMENTAL PROCEDURES
Cell Culture and Mice
Mouse embryonic fibroblasts (MEFs) and tail-tip fibroblasts (TTFs) were iso-
lated as previously described (Wernig et al., 2008). MEFs and TTFs were
grown in DMEM supplemented with 10% FBS, 2 mM L-glutamine, and anti-
biotics. ESCs and iPSCs were grown in DMEM supplemented with 15% FBS,
1% non-essential amino acids, 2 mM L-glutamine, 2 3 106 units mouse
Leukemia inhibitory factor (mLif), 0.1 mM b-mercaptoethanol (Sigma), and
antibiotics with or without 2i- PD0325901 (1 mM) and CHIR99021 (3 mM)
(Tocris). For primary infection, MEFs were isolated from mice heterozygous
for the reverse tetracycline-dependent transactivator (M2rtTA) that resides
in the ubiquitously expressed Gt(ROSA)26Sor locus alone, or in combination
with GFP that was either knocked-in to the Sox2, Nanog, or the Oct4 locus.
All infections were performed on MEFs (passage 0 or 1) that were seeded at
70% confluence 2 days prior to the first infection. Blastocyst-derived
(bdTSC) lines were isolated as described (Oda et al., 2006). TSCs and stable
iTSCs were grown in TSC culturing medium: a combined TSC medium con-
taining 30% RPMI supplemented with 20% FBS, 1% non-essential amino
acids, 2 mM L-glutamine, 25 ng/ml human recombinant FGF4 (PeproTech)
and 1 mg/ml heparin (Sigma-Aldrich), and 70% MEF conditioned media
(MEF-CM) with the same supplements. For culture of bdTSCs and stable
iTSCs in defined medium, cells were grown on GFR-Matrigel-coated dishes
in TX medium as described previously (Kubaczka et al., 2014). For differen-
tiation experiments, DMEM supplemented with 10% FBS, 2 mM L-gluta-
mine, and antibiotics was used. MEFs were directly converted into
cardiomyocytes as previously reported (Efe et al., 2011). The joint ethics
committee (IACUC) of the Hebrew University and Hadassah Medical Center
approved the study protocol for animal welfare. The Hebrew University is an
AAALAC international accredited institute.
Molecular Cloning, Lentiviral Infection, and Reprogramming
to iTSCs
The 12 dox-inducible TSC factors were generated by cloning the open reading
frame of each factor, obtained by reverse transcription with specific primers
(see the Primer List in the Supplemental Information), into the TOPO-TA vector
(Invitrogen) and then restricted with EcoRI or MfeI and inserted into the FUW-
TetO expression vector.
For infection, replication-incompetent lentiviruses containing the GET
factors (3.5 mg of each) or the GETM factors (3 mg of GET and 1 mg of M)
were packaged with a lentiviral packaging mix (7.5 mg psPAX2 and 2.5 mg
pGDM.2) in 293T cells and collected 48, 60, and 72 hr after transfection.
The supernatants were filtered through a 0.45 mm filter, supplemented
with 8 mg/ml of polybrene (Sigma), and then used to infect MEFs or TTFs.
Six hours following the third infection, medium was replaced with fresh
DMEM containing 10% FBS. Eighteen hours later, medium was replaced to
TSC reprogramming medium (RPMI supplemented with 20% FBS, 0.1 mM
b-mercaptoethanol, 2 mM L-glutamine, 25 ng/ml human recombinant FGF4
[PeproTech], 1 mg/ml heparin [Sigma-Aldrich], and 2 mg/ml doxycycline).
TSC reprogramming medium was changed every other day for 20 days,
followed by 10 days in TSC culturing medium (see above). Ten days after
dox removal, plates were screened for primary iTSC colonies. Each colony
was isolated, trypsinized, and plated in a separate well in a 6-well plate on
feeder cells. Wells were followed and medium was replaced every other day
for five to ten passages, until stable iTSC colonies developed.
Hemorrhagic Lesion Formation
A total of 5 3 106 iTSCs were resuspended in 100 ml CM containing hFGF4
and injected subcutaneously into male athymic nude mice. After 7 days,
lesions were dissected, fixed in 4% paraformaldehyde overnight, embedded
in paraffin, and sectioned (4 mm). Sections were stainedwith H&E and analyzed
by a certified pathologist.
Chimeric Embryo and Placenta Contribution
Blastocyst injections were performed using CB6F1 host embryos. After prim-
ing with PMSG and hCG hormones and mating with CB6F1 males, embryos
were obtained at 3.5 dpc (blastocyst stage) for chimera assay and 0.5 dpc
(1-cell stage) and then cultured until 8-cell stage for staining. Embryos554 Cell Stem Cell 17, 543–556, November 5, 2015 ª2015 Elsevier In(0.5 dpc) were cultured in Evolve KSOMaa (Zenith Biotech) until reaching
8-cell stage embryo and then were injected with 10–20 bdTSCs or iTSCs.
Eight-cell-stage embryos or 3.5 dpc blastocysts were injected with a flat tip
microinjection pipette with an internal diameter of 16 mm (Origio) in drop of
Evolve with HEPES KSOMaa (Zenith Biotech) medium under mineral oil.
Shortly after injection, blastocysts were transferred to 2.5 dpc pseudopreg-
nant CD1 females (20 blastocysts per female). Eight-cell stage embryos
were grown in Evolve KSOMaa (Zenith Biotech) until the blastocyst stage
and then were fixed and subjected to immunostaining. Chimeric embryos or
placentas were isolated at E13.5.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, one table, and two movies and can be found with this article online
at http://dx.doi.org/10.1016/j.stem.2015.08.006.
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